Press Releases Latest Sep 26, 2023 Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates Press Releases Year None20232022202120202019201820172016201520142013 Dec 06, 2021 Theratechnologies Submits Supplemental Biologics License Application to FDA Advancing Development of IV Push Trogarzo® for Patients Living With HIV Nov 26, 2021 Theratechnologies Named Recipient of the 2021 ADRIQ Innovation Award in the "Life Sciences" Category Nov 23, 2021 Theratechnologies Announces Renewal of Shelf Prospectus and Registration Statement; At-The-Market Facility to be Extended Nov 03, 2021 Theratechnologies to Present at the Credit Suisse 30th Annual Healthcare Conference on November 11, 2021 Oct 26, 2021 Theratechnologies Announces Reimbursement Agreement in Italy for Trogarzo® for Eligible Patients With Multi-Drug Resistant HIV-1 Oct 22, 2021 Theratechnologies Announces Publication in Frontiers in Oncology Journal Highlighting SORT1+ Technology™ for Targeting SORT1-Mediated Vasculogenic Mimicry Oct 13, 2021 Theratechnologies Reports Financial Results for the Third Quarter of Fiscal 2021 and Provides Business Update Oct 06, 2021 Theratechnologies to Present at the H.C. Wainwright 5th Annual Nash Investor Conference Sep 29, 2021 Theratechnologies to Announce Financial Results for Its Third Quarter Fiscal 2021 Sep 22, 2021 Theratechnologies Announces Positive Results for Trogarzo® IV Push Administration Study First page « Previous page ‹ … Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Page 10 Page 11 … Next page › Last page » Displaying 61 - 70 of 328
Sep 26, 2023 Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates
Dec 06, 2021 Theratechnologies Submits Supplemental Biologics License Application to FDA Advancing Development of IV Push Trogarzo® for Patients Living With HIV
Nov 26, 2021 Theratechnologies Named Recipient of the 2021 ADRIQ Innovation Award in the "Life Sciences" Category
Nov 23, 2021 Theratechnologies Announces Renewal of Shelf Prospectus and Registration Statement; At-The-Market Facility to be Extended
Nov 03, 2021 Theratechnologies to Present at the Credit Suisse 30th Annual Healthcare Conference on November 11, 2021
Oct 26, 2021 Theratechnologies Announces Reimbursement Agreement in Italy for Trogarzo® for Eligible Patients With Multi-Drug Resistant HIV-1
Oct 22, 2021 Theratechnologies Announces Publication in Frontiers in Oncology Journal Highlighting SORT1+ Technology™ for Targeting SORT1-Mediated Vasculogenic Mimicry
Oct 13, 2021 Theratechnologies Reports Financial Results for the Third Quarter of Fiscal 2021 and Provides Business Update
